Breaking Barriers: Mastering the Challenges of GLP-1 Drug Trials 

Zoom Webinar

You’re invited to join industry leaders from WCG and Kailera Therapeutics in an engaging discussion about the multifaceted challenges faced by sponsors and sites in bringing GLP-1 drugs to market. This webinar is designed for researchers, clinicians, pharmaceutical professionals, and healthcare stakeholders who are keen to understand the complexities and solutions in the clinical development and trial process for GLP-1 drugs. 

Webinar Highlights: 

  • Understanding GLP-1 Drugs and Their Explosive Growth: Dive into the mechanisms and applications of GLP-1 receptor agonists in managing Type 2 diabetes mellitus, obesity, and related conditions and why these drugs are skyrocketing in the market.  
  • Challenges in Clinical Trials: Explore the top challenges that both sponsors and sites face during clinical trials. From participant recruitment and retention to regulatory hurdles and logistical issues, gain insights into the critical pain points and how to address them effectively. 
  • Innovative Solutions: Discover how sponsors can support sites through flexibility and innovative protocol design, and how sites can support sponsors through robust enrollment and retention programs 
  • Case Studies and Best Practices: Learn about recent real-world scenarios and best practices for successfully navigating the challenges of developing GLP-1s from bench to bedside, and what lessons can be applied to your own studies. 

Why Attend? 

  • Gain a comprehensive understanding of the challenges and solutions in GLP-1 drug trials. 
  • Learn from industry leaders and experts with firsthand experience. 
  • Discover innovative strategies to enhance clinical trial success. 

Presenters:

Patrick Harrington, PhD

SVP, Clinical Solutions and Strategic Partnering, WCG

Manny Lazaro

Senior Vice President, Clinical Development Operations, Kailera Therapuetics